Evaluation of background PSMA uptake in benign prostate tissue revealed a median SUVmean of 2.20 (95% CI: 2.00–2.40) for atrophy/inflammation and 2.40 (95% CI: 2.20–2.70) for benign prostatic hyperplasia. Here, FOLH1 is linked to benign prostatic hyperplasia.